
A simple blood test could revolutionise treatment for lupus patients who do not respond to existing therapies, researchers say.
Previous studies have shown that patients with treatment-resistant lupus who are positive for the biomarker are 17 times more likely to respond to an innovative combination of drugs, which are available on the NHS but not currently used together.